A carregar...
Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review
Failure in cancer drug development exacts heavy burdens on patients and research systems. To investigate inefficiencies and burdens in targeted drug development in cancer, we conducted a systematic review of all prelicensure trials for the anticancer drug, sorafenib (Bayer/Onyx Pharmaceuticals). We...
Na minha lista:
| Publicado no: | PLoS Biol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5291369/ https://ncbi.nlm.nih.gov/pubmed/28158308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pbio.2000487 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|